Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback